Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases.

Our Work Spans The Vaccine Landscape

Partnering for Impact

Collaboration lies at the heart of our work. Our partners include other nonprofit organizations, global and funding agencies, academic and scientific institutions, and companies. Our partners are located all over the world — from Asia to Africa to South America. Below are some of the organizations we work with.

Our Partnerships


Adaptive Change Advisors
Aga Khan University
Agência Bori
Alliance for Advancing Health Online
Aspen Institute
Bay Area Global Health Alliance
Bill and Melinda Gates Foundation
Bull City Learning
Center for Open Science
Child Health Research Foundation
Clinton Health Access Initiative
Coalition for Epidemic Preparedness Innovations (CEPI)
CORE Group
Dalberg Advisors
Dhulikhel Hospital
Frontline Health Workers Coalition
Fundação Oswaldo Cruz
Gavi, the Vaccine Alliance
Global Health Council
Global Health Technologies Coalition


Influenza Vaccines Roadmap Initiative (IVR)
International Association of Public Health Logisticians
International Vaccine Access Center (IVAC)
International Vaccine Institute
International Women’s Media Foundation
John Snow, Inc. (JSI)
Kathmandu Model Hospital
Kharadar General Hospital
Linked Immunisation Action Network
Massachusetts General Hospital
Nature Research Custom Media
Oklahoma Blood Institute
Pandemic Action Network
Paukwa House
People. Power. Health.
Project ECHO


ReiThera, SRL
Rockefeller Foundation
Shishu Sasthya Foundation
Stanford University
The Curve
The EPI Leadership and Management Program
The Geneva Learning Foundation
The Global Funders Consortium for Universal Influenza Vaccine Development
The Guardian + Media Planet
UC Davis
University of Maryland
Vaccine Research Center/NIAID
World Health Organization
Zero-Dose Community of Practice


R&D Partnership Philosophy

Sabin engages in clinical research through partnerships. Sabin’s goal is to enter partnerships that provide broader, timely access to data to improve decision-making in global vaccine development and licensing/pre-qualification strategies and ultimately drive better outcomes for the populations we seek to serve.

Partnership Case Study

Elevating Local Data for Global Decision Making

In 2014, we began studying the impact of typhoid on communities in affected areas of Bangladesh, Pakistan and Nepal through partnerships with local hospitals, laboratories, researchers and health officials. Our landmark Surveillance for Enteric Fever in Asia Project has since contributed to the WHO and Gavi decisions around new typhoid conjugate vaccine use. It continues to inform country-level policies to curb typhoid’s spread.

Partnership Case Study

Leveraging Lessons From COVID-19 for Vaccine R&D

The record-breaking response of the scientific community in developing COVID-19 vaccines demonstrates the power of cooperation, government commitment and regulatory flexibility. The Sabin-Aspen Vaccine Science & Policy Group explored real-time lessons from this work and the vaccine ecosystem. Their report shares five “Big Ideas” to rethink the development of vaccines to help prevent future pandemics and check ongoing disease threats like malaria, TB and HIV.